Total-body irradiation with high-LET particles: acute and chronic effects on the immune system

Daila S. Gridley1,2, Michael J. Pecaut1, Gregory A. Nelson1
1Departments of Radiation Medicine, Radiobiology Program, and
2Microbiology and Molecular Genetics, Loma Linda University and Medical Center, Loma Linda, California 92354

Tóm tắt

Although the immune system is highly susceptible to radiation-induced damage, consequences of high linear energy transfer (LET) radiation remain unclear. This study evaluated the effects of 0.1 gray (Gy), 0.5 Gy, and 2.0 Gy iron ion (56Fe26) radiation on lymphoid cells and organs of C57BL/6 mice on days 4 and 113 after whole body exposure; a group irradiated with 2.0 Gy silicon ions (28Si) was euthanized on day 113. On day 4 after 56Fe irradiation, dose-dependent decreases were noted in spleen and thymus masses and all major leukocyte populations in blood and spleen. The CD19+ B lymphocytes were most radiosensitive and NK1.1+ natural killer (NK) cells were most resistant. CD3+ T cells were moderately radiosensitive and a greater loss of CD3+/CD8+TC cells than CD3+/CD4+TH cells was noted. Basal DNA synthesis was elevated on day 4, but response to mitogens and secretion of interleukin-2 and tumor necrosis factor-α were unaffected. Signs of anemia were noted. By day 113, high B cell numbers and low TC cell and monocyte percents were found in the 2.0 Gy56Fe group; the 2.0 Gy 28Si mice had low NK cells, decreased basal DNA synthesis, and a somewhat increased response to two mitogens. Collectively, the data show that lymphoid cells and tissues are markedly affected by high linear energy transfer (LET) radiation at relatively low doses, that some aberrations persist long after exposure, and that different consequences may be induced by various densely ionizing particles. Thus simultaneous exposure to multiple radiation sources could lead to a broader spectrum of immune dysfunction than currently anticipated.

Từ khóa


Tài liệu tham khảo

10.2307/3578551

10.2307/3578823

10.1152/ajpendo.1994.267.6.E822

10.1007/BF01211537

10.1002/(SICI)1097-0320(19980101)31:1<45::AID-CYTO6>3.0.CO;2-I

10.1667/0033-7587(2000)154[0389:QIAOLI]2.0.CO;2

10.1016/0273-1177(89)90452-3

10.2307/3579784

10.2307/3579716

10.2307/3579170

Erofeeva LM, 2000, Morfologiia, 117, 42

Gridley DS, 1997, Anticancer Res, 17, 923

10.1016/S0165-2478(01)00306-6

Gridley DS, 2001, In Vivo, 15, 209

Grigorenko DE, 1998, Morfologiia, 114, 80

10.1111/j.1365-2249.1997.272-ce1158.x

Hau DM, 1996, Chin Med J (Engl), 106, 143

10.2307/3578395

10.1016/S0304-3835(96)04481-3

Huiskamp R, 1985, J Immunol, 134, 2161

Huiskamp R, 1985, J Immunol, 134, 2170

10.2307/3578216

10.1016/0027-5107(91)90152-E

10.1667/0033-7587(2000)153[0587:AEOWBP]2.0.CO;2

Kajioka EH, 2001, In Vivo, 14, 703

Kajioka EH, 1999, In Vivo, 13, 525

10.2307/3572023

10.1021/j100463a008

10.1080/09553008614550601

Meyer OT, 1970, J Reticuloendothel Soc, 7, 79

10.1080/09553009314552181

10.1667/0033-7587(2000)153[0729:ICDRFT]2.0.CO;2

10.1016/S0165-2478(01)00307-8

Pecaut MJ, 2001, In Vivo, 15, 195

10.1152/ajpregu.2000.279.6.R2072

10.2307/3575359

Rowley DA, 1993, Aviat Space Environ Med, 64, 528

Sapin MR, 1999, Vestn Ross Akad Med Nauk, 12, 41

10.1016/S0165-2478(99)00074-7

10.2307/3578250

10.1152/jappl.1992.73.2.S191

10.1016/0360-3016(82)90554-5

10.2307/3583713

10.1016/S0027-5107(99)00132-3

10.1016/S0027-5107(99)00137-2

10.2307/3579723

10.1080/095530099140230

10.2307/3583525

10.1002/(SICI)1520-6823(1997)5:3<134::AID-ROI10>3.0.CO;2-6

10.2307/3579902

10.1103/PhysRevC.56.388